| [1] |
Verslype C, Rosmorduc O, Rougier P, et al. Hepatocellular carcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2012, 23 suppl 7:vii41-48.
|
| [2] |
Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update[J]. J Vasc Interv Radiol, 2014, 25(11):1691-1705.
|
| [3] |
Seror O, N'Kontchou G, Ibraheem M, et al. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients[J]. Radiology, 2008, 248(1):288-296.
|
| [4] |
Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis[J]. Ann Surg, 2000, 232(3):381-391.
|
| [5] |
中国抗癌协会肝癌专业委员会，中国抗癌协会临床肿瘤学协作委员会，中华医学会肝病学分会肝癌学组．原发性肝癌规范化诊治专家共识[J]．临床肿瘤学杂志，2009，14(3):259-269.
|
| [6] |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3):321-328.
|
| [7] |
Feliu J, Sastre J, Maurel J, et al. Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines[J]. Clin Transl Oncol, 2011, 13(8):536-544.
|
| [8] |
European Association for Study of Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. Eur J Cancer, 2012, 48(5):599-641.
|
| [9] |
Tan CH, Low SC, Thng CH. APASL and AASLD consensus guidelines on imaging diagnosis of hepatocellular carcinoma: a review[J]. Int J Hepatol, 2011:519783.
|
| [10] |
Zhang CS, Zhang JL, Li XH, et al. Is radiofrequency ablation equal to surgical re-resection for recurrent hepatocellular carcinoma meeting the Milan criteria? a meta-analysis[J]. J BUON, 2015, 20(1):223-230.
|
| [11] |
Fu C, Liu N, Deng Q, et al. Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials[J]. Hepatogastroenterology, 2014, 61(134):1722-1729.
|
| [12] |
Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation[J]. Hepatology, 2005, 41(5):1130-1137.
|
| [13] |
Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study[J]. Ann Surg, 2004, 240(5):900-909.
|
| [14] |
Chen QW, Ying HF, Gao S, et al. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2016, 40(3):309-314.
|
| [15] |
Xu C, Lv PH, Huang XE, et al. Efficacy of transarterial chemoembolization combined with radiofrequency ablation in treatment of hepatocellular carcinoma[J]. Asian Pac J Cancer Prev, 2015, 16(14):6159-6162.
|
| [16] |
Kim JH, Won HJ, Shin YM, et al. Medium-sized (3.1-5.0 cm)hepatocellular carcinoma：transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone[J]. Ann Surg Oncol, 2011, 18(6):1624-1629.
|
| [17] |
Morimoto M, Numata K, Kondou M, et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization[J]. Cancer, 2010, 116(23):5452-5460.
|
| [18] |
Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)[J]. Eur Radiol, 2006, 16(3):661-669.
|
| [19] |
Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial[J]. Radiology, 2007, 244(2):599-607.
|
| [20] |
Bouza C, López-Cuadrado T, Alcázar R, et al. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma[J]. BMC Gastroenterol, 2009, 11(9):31.
|
| [21] |
Kan X, Jing Y, Wan QY, et al. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2015, 19(2):247-255.
|
| [22] |
Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study[J]. Radiology, 2003, 226(2):441-451.
|
| [23] |
Fonseca AZ, Saad WA, Ribeiro MA Jr. Complications after radiofrequency ablation of 233 hepatic tumors[J]. Oncology, 2015, 89(6):332-336.
|
| [24] |
Yamasaki T, Kurokawa F, Shirahashi H, et al. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. comparison with standard percutaneous radiofrequency ablation therapy[J]. Cancer, 2002, 95(11):2353-2360.
|
| [25] |
de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion[J]. AJR Am J Roentgenol, 2002, 178(1):53-59.
|
| [26] |
Nam SY, Rhim H, Kang TW, et al. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites[J]. AJR Am J Roentgenol, 2010, 194(2):W227-231.
|
| [27] |
Stavrou GA, Donati M, Fruehauf NR, et al. Liver resection using heat coagulative necrosis: indications and limits of a new method[J]. ANZ J Surg, 2009, 79(9):624-628.
|